Evidence map›Paper›PMID 39780349›Full record

ArticleClinical nuclear medicine2025

18 F-FAZA, 18 F-FDG, and 123 I-IMP Imaging Reveal Hypoxia and Metabolism in Acute MOGAD.

Kota Yokoyama, Junichi Tsuchiya, Hiroya Kuwahara, Motoki Inaji, Ukihide Tateishi

Abstract readCase Reports
In one paragraph

Article in Clinical nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kota YokoyamaFrom the Departments of Diagnostic Radiology.ORCID 0000-0001-5151-3146
Junichi TsuchiyaFrom the Departments of Diagnostic Radiology.
Hiroya KuwaharaNeurology.
Motoki InajiNeurosurgery, Institute of Science Tokyo, Tokyo, Japan.
Ukihide TateishiFrom the Departments of Diagnostic Radiology.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractWe report the first case of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) evaluated with hypoxic imaging using 18 F-FAZA PET/CT. A healthy woman in her 20s presented to our hospital with seizures, headaches, and vomiting. MRI and CT scans suggested a wide range of differential diagnoses, from neoplastic lesions, such as malignant lymphoma, to inflammatory diseases, such as vasculitis, making her case challenging to diagnose. MOGAD was confirmed by positive myelin oligodendrocyte glycoprotein antibodies, and her condition improved with steroid therapy. The 18 F-FAZA PET/CT findings in this case may aid in understanding the pathogenesis of MOGAD.

Indexed as

Fluorodeoxyglucose F18HypoxiaMyelin-Oligodendrocyte GlycoproteinMyelin Oligodendrocyte Glycoprotein Antibody-Associated DiseasePositron Emission Tomography Computed TomographyAcute DiseaseAdultFemaleHumansFluorodeoxyglucose F18Myelin-Oligodendrocyte Glycoprotein

Identifiers

PMID39780349
PMCPMC11878587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.